MAIA Biotechnology, Inc. (MAIA) is currently trading at $1.38 with a Wall Street consensus price target of $12.13, implying potential upside of 779.3% over the next 12 months. 2 analysts currently cover MAIA, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $14.0, while the most cautious has a target of $10.27.
MAIA operates in the Healthcare sector with a market capitalisation of $84M. The stock is down 13.8% year-to-date and is currently trading near the lower end of its 52-week range of $0.87 – $3.19.
Other Healthcare stocks with comparable size and valuation.
Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.
Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.
StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.
View Full Rankings →